智库专家

专家动态

当前位置：网站首页 >> 智库专家 >> 查看详情

李朝辉

Dr.ZhaohuiLiisAccountManager,NAMSAChina.ZhaohuimostrecentlyworkedinTUVSUDSingaporelabasaGLPStudyDirector.Hemanagedmorethan150GLPsafetyandefficacystudies,includingprotocoldevelopment,studyexecution,andfinalreport.ZhaohuihadtechnicalexpertiseinELISA,boneandmuscleimplant,intradermalinjection,IVIPinjectionandmanyotherhands-onlabexperiences.Zhaohuiwasalsoinvolvedinmarketdevelopment,training,speaking,andsalesteamdevelopmentforTUVSUDChinatestingbusinesseffort.BeforeTUVSUD,ZhaohuiworkedinNationalCancerCenterSingaporeasaresearchfellow,wherehemanagedalungcancerclinicalstudy;workedinNationalUniversityofSingaporeasaresearchofficerstudyingonneurodegenerativedisease.ZhaohuiobtainedhisPh.D.inneurosciencefromNationalUniversityofSingaporeandBSinBiochemicalPharmaceuticsfromJilinUniversity,China.

http://www.zcmsonline.com/index.php/zkzj/100888.html

联系方式：
手机号码：
联系邮箱：
助理电话：

详细介绍

Dr. Zhaohui Li is Account Manager, NAMSA China. Zhaohui most recently worked in TUV SUD Singapore lab as a GLP Study Director. He managed more than 150 GLP safety and efficacy studies, including protocol development, study execution, and final report. Zhaohui had technical expertise in ELISA, bone and muscle implant, intradermal injection, IV IP injection and many other hands-on lab experiences. Zhaohui was also involved in market development, training, speaking, and sales team development for TUV SUD China testing business effort. Before TUV SUD, Zhaohui worked in National Cancer Center Singapore as a research fellow, where he managed a lung cancer clinical study; worked in National University of Singapore as a research officer studying on neurodegenerative disease. Zhaohui obtained his Ph.D. in neuroscience from National University of Singapore and BS in Biochemical Pharmaceutics from Jilin University, China.

上一篇：郑卫东

下一篇：何文法